Asahi Kasei Medical
  • Site Map
  • Contact Us
  • Font size: Small
  • Font size: Medium
  • Font size: Large
  • Home
  • Our Approach to Business
  • Corporate Information
  • News
  • Products
  • Patients and Families

References by Products

Literature containing information about our products for hemodialysis.

APS series

Featured references

Honda et al.
Effect of polysulfone membrane dialyzers on the coagulation system.
Jpn. J. High Performance Membrane '05, Kidney and Dialysis, Suppl., 59: 77-81, 2005
Miyawaki et al.
Comparison of Biocompatibility and Solute Removal Between Asahi Polysulfone APS-U and Other Dialyzers.
Jpn. J. High Performance Membrane '03, Kidney and Dialysis Suppl 55: 126-129, 2003

Top of Page

APS

Motomura et al.
Removal of β2-MG from dialysis patients.
Jpn. J. High Performance Membrane '00, Kidney and Dialysis, Vol. 49 supplement, P. 113-117, 2000
Klingel et al.
Enhanced Functional Performance Characteristics of a New Poysulfone Membrane for High-Flux Hemodialysis.
Blood Purif; 20:325-333, 2002
Asahi Kasei Medical Ltd.
CLINICAL BENEFITS OF β2-MICROGLOBULIN REMOVAL, 2004
Yamane et al.
Evaluation of Several PS Membranes for Performance in Eliminating Low Molecular Weight Proteins (LMWPs), From the Point of Albumin Loss into Account.
Jpn. J. High Performance Membrane '99, Kidney and Dialysis, Vol. 47 supplement, P. 110-113, 1999
Motomura et al.
Importance of β2-microglobulin removal in chronic renal replacement therapy.
Jpn. J. High Performance Membrane '99, Kidney and Dialysis, Vol. 47 supplement, P. 136-139, 1999
Sohka et al.
uPAR (CD87) as a Biocompatibility Marker of Dialysis Membrane.
Blood Purif 2006; 24:236-246
Mandolfo et al.
Leptin and β2-microglobulin kinetics with three different dialysis modalities.
THE INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS Vol. 29 / no. 10, pp. 949-955, 2006

Top of Page

APS-H

Asahi Kasei Medical Ltd.
CLINICAL BENEFITS OF β2-MICROGLOBULIN REMOVAL, 2004
Yamane et al.
Evaluation of Several PS Membranes for Performance in Eliminating Low Molecular Weight Proteins (LMWPs), From the Point of Albumin Loss into Account.
Jpn. J. High Performance Membrane '99, Kidney and Dialysis, Vol. 47 supplement, P. 110-113, 1999
Motomura et al.
Importance of β2-microglobulin removal in chronic renal replacement therapy.
Jpn. J. High Performance Membrane '99, Kidney and Dialysis, Vol. 47 supplement, P. 136-139, 1999
Sohka et al.
uPAR (CD87) as a Biocompatibility Marker of Dialysis Membrane.
Blood Purif, 24:236-246, 2006
Mandolfo et al.
Leptin and β2-microglobulin kinetics with three different dialysis modalities.
THE INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS Vol. 29 / no. 10, pp. 949-955, 2006

Top of Page

APS-U

Honda et al.
Effect of polysulfone membrane dialyzers on the coagulation system.
Jpn. J. High Performance Membrane '05, Kidney and Dialysis, Suppl., 59: 77-81, 2005
Miyawaki et al.
Comparison of Biocompatibility and Solute Removal Between Asahi Polysulfone APS-U and Other Dialyzers.
Jpn. J. High Performance Membrane '03, Kidney and Dialysis Suppl 55: 126-129, 2003
Suzuki et al.
Clinical Evaluation of Asahi Polysulfone APS-15U.
Jpn. J. High Performance Membrane '03, Kidney and Dialysis, Suppl 55: 59-63, 2003
Asahi Kasei Medical Ltd.
CLINICAL BENEFITS OF β2-MICROGLOBULIN REMOVAL, 2004
Yamane et al.
Evaluation of Several PS Membranes for Performance in Eliminating Low Molecular Weight Proteins (LMWPs), From the Point of Albumin Loss into Account.
Jpn. J. High Performance Membrane '99, Kidney and Dialysis, Vol. 47 supplement, P. 110-113, 1999
Motomura et al.
Importance of β2-microglobulin removal in chronic renal replacement therapy.
Jpn. J. High Performance Membrane '99, Kidney and Dialysis, Vol. 47 supplement, P. 136-139, 1999
Sohka et al.
uPAR (CD87) as a Biocompatibility Marker of Dialysis Membrane.
Blood Purif, 24:236-246, 2006
Mandolfo et al.
Leptin and β2-microglobulin kinetics with three different dialysis modalities.
THE INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS Vol. 29 / no. 10, pp. 949-955, 2006

Top of Page

REXEED series

Featured references

Brendolan et al.
Dialytic performance evaluation of Rexeed: A new polysulfone-based dialyzer with improved flow distributions.
THE INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS Vol. 28, no. 10, pp. 966-975, 2005
Nakamura et al.
Performance Evaluation of REXEED-15A.
Jpn. J. High Performance Membrane '05, Kidney and Dialysis, Suppl., 59: 145-149, 2005

Top of Page

REXEED-A

Brendolan et al.
Dialytic performance evaluation of Rexeed™: A new polysulfone-based dialyzer with improved flow distributions.
THE INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS Vol. 28, no. 10, pp. 966-975, 2005
Nakamura et al.
Performance Evaluation of REXEED-15A.
Jpn. J. High Performance Membrane '05, Kidney and Dialysis, Suppl., 59: 145-149, 2005
Taguchi et al.
Effects of differences in dialyzers and anti-coagulant dosage on blood activation.
Jpn. J. High Performance Membrane '06, Kidney and Dialysis, Suppl., 61:206-209, 2006
Osawa et al.
The Characteristics of Dialyzers When Used for High-volume Pre-dilution On-line Hemodiafiltration.
Jpn. J. High Performance Membrane '08, Kidney and Dialysis, Suppl., 65:133-135, 2008
James B.Post, MD.
Thrombocytopenia Associated With Use of a Biocompatible Hemodialysis Membrane: A Case Report.
American Journal of Kidney Diseases, Vol 55, No 6 (June), e25-e28, 2010
Hoshiyama et al.
A study of dialysis conditions in patients with high body weight.
Jpn. J. High Performance Membrane '05, Kidney and Dialysis, Suppl., 59:39-43, 2005
Abe et al.
Clinical evaluation of plasma insulin and C-peptide levels with 3 different high-flux dialyzers in diabetic patients on hemodialysis.
The international JOURNAL OF ARTIFICIAL ORGANS Vol.31, No. 10, pp. 898-904, 2008

Top of Page

REXEED-L

James B.Post, MD.
Thrombocytopenia Associated With Use of a Biocompatible Hemodialysis Membrane: A Case Report.
American Journal of Kidney Diseases, Vol 55, No 6 (June), e25-e28, 2010
Hoshiyama et al.
A study of dialysis conditions in patients with high body weight.
Jpn. J. High Performance Membrane '05, Kidney and Dialysis, Suppl., 59:39-43, 2005
Abe et al.
Clinical evaluation of plasma insulin and C-peptide levels with 3 different high-flux dialyzers in diabetic patients on hemodialysis.
The international JOURNAL OF ARTIFICIAL ORGANS Vol.31, No. 10, pp. 898-904, 2008

Top of Page

ViE series

Featured references

M. Aritomi (Asahi Kasei Kuraray Medical Co. Ltd.), F. Galli (University of Perugia, Italy).
Review of the Effectiveness of Cellulose- and Polysulfone-Based Vitamin E-Bonded Dialysis Membranes.
InTech, 2011

Top of Page

ViE-A

Floridi et al.
Analysis method and characterization of the antioxidant capacity of vitamin E-interactive polysulfone hemodialyzers.
Acta Biomater. 5(8):2974-82, 2009
Panichi et al.
A Vitamin E-Coated Polysulfone Membrane Reduces Serum Levels of Inflammatory Markers and Resistance to Erythropoietin-Stimulating Agents in Hemodialysis Patients: Results of a Randomized Cross-Over Multicenter Trial.
Blood Purif. 32(1):7-14, 2011
Morimoto et al.
Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients.
Nephrol Dial Transplant. 20(12):2775-82, 2005
Calo et al.
Molecular Biology-Based Assessment of Vitamin E-Coated Dialyzer Effects on Oxidative Stress, Inflammation, and Vascular Remodeling.
Artif Organs. 35(2):E33-9, 2011
Sasaki et al.
Development of vitamin E-modified polysulfone membrane dialyzers.
Journal of Artificial Organs Vol. 9, No. 1, 2006
Matsumura et al.
Improved management of intradialytic hypotension (IDH) using vitamin E-bonded polysulfone membrane dialyzer.
The international JOURNAL OF ARTIFICIAL ORGANS Vol. 33, No. 3, pp. 147-153, 2010

Top of Page

ViE

Floridi et al.
Analysis method and characterization of the antioxidant capacity of vitamin E-interactive polysulfone hemodialyzers.
Acta Biomater. 5(8):2974-82, 2009
Panichi et al.
A Vitamin E-Coated Polysulfone Membrane Reduces Serum Levels of Inflammatory Markers and Resistance to Erythropoietin-Stimulating Agents in Hemodialysis Patients: Results of a Randomized Cross-Over Multicenter Trial.
Blood Purif. 32(1):7-14, 2011
Morimoto et al.
Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients.
Nephrol Dial Transplant. 20(12):2775-82, 2005
Calo et al.
Molecular Biology-Based Assessment of Vitamin E-Coated Dialyzer Effects on Oxidative Stress, Inflammation, and Vascular Remodeling.
Artif Organs. 35(2):E33-9, 2011
Sasaki et al.
Development of vitamin E-modified polysulfone membrane dialyzers.
Journal of Artificial Organs Vol. 9, No. 1, 2006
Matsumura et al.
Improved management of intradialytic hypotension (IDH) using vitamin E-bonded polysulfone membrane dialyzer.
The international JOURNAL OF ARTIFICIAL ORGANS Vol. 33, No. 3, pp. 147-153, 2010

Top of Page

ViE-L

Floridi et al.
Analysis method and characterization of the antioxidant capacity of vitamin E-interactive polysulfone hemodialyzers.
Acta Biomater. 5(8):2974-82, 2009
Panichi et al.
A Vitamin E-Coated Polysulfone Membrane Reduces Serum Levels of Inflammatory Markers and Resistance to Erythropoietin-Stimulating Agents in Hemodialysis Patients: Results of a Randomized Cross-Over Multicenter Trial.
Blood Purif. 32(1):7-14, 2011
Morimoto et al.
Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients.
Nephrol Dial Transplant. 20(12):2775-82, 2005
Calo et al.
Molecular Biology-Based Assessment of Vitamin E-Coated Dialyzer Effects on Oxidative Stress, Inflammation, and Vascular Remodeling.
Artif Organs. 35(2):E33-9, 2011
Sasaki et al.
Development of vitamin E-modified polysulfone membrane dialyzers.
Journal of Artificial Organs Vol. 9, No. 1, 2006
Matsumura et al.
Improved management of intradialytic hypotension (IDH) using vitamin E-bonded polysulfone membrane dialyzer.
The international JOURNAL OF ARTIFICIAL ORGANS Vol. 33, No. 3, pp. 147-153, 2010

Top of Page

KF-201 series

Featured references

Bonomini et al.
Heterotypic Cell Interactions in Hemodialysis Patients.
Biocompatibility of Dialytic Membrane (pp. 58-80), 2010
Akiyoshi Nakano.
Ethylene Vinyl Alcohol Co-Polymer as a High-Performance Membrane: An EVOH Membrane with Excellent Biocompatibility.

Top of Page

KF-201-C

Pertosa et al.
Coagulation Cascade Activation Causes CC Chemokine Receptor-2 Gene Expression and Mononuclear Cell Activation in Hemodialysis Patients.
American Society of Nephrology 16: 2477-2486, 2005
Sirolli et al.
Cell activation and cellular-cellular interactions during hemodialysis: Effect of dialyzer membrane.
THE INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS Vol. 25 / no. 6, pp. 529-537, 2002
Sirolli et al.
LEUKOCYTE ADHESION MOLECULES AND LEUKOCYTE-PLATELET INTERACTIONS DURING HEMODIALYSIS: EFFECTS OF DIFFERENT SYNTHETIC MEMBRANES.
THE INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS Vol. 22, no. 8, pp. 536-542, 1999
Mitsuru Ishizaki, M.D.
Optimum condiitons for continuous use of high-performance membranes - The characteristics of the EVAL membrane in terms of urea kinetics -.
The Kidney Center, Eijinkai-Nagano Hospital, 1998
Masao Ishida.
Blood Compatibility of Ethylene-Vinyl Alcohol Copolymer Dialyzer.
The Cell (Japanese Journal, Hokuryukan & New Science Co., Ltd.) 37: 68-72, 2005
Bonomini et al.
Heterotypic Cell Interactions in Hemodialysis Patients.
Biocompatibility of Dialytic Membrane, pp. 58-80, 2010
Pertosa et al.
Biocompatibility profile of Ethylen-vinyl-alcohol (EVAL), a synthetic dialytic membrane with reduced coagulation and inflammatory activity.
Biocompatibility of Dialytic Membrane, pp.82-106, 2010
Yokota et al.
Use of ethylene vinyl-alcohol block copolymer (EVAL™) dialyzers in the treatment of elderly patients.
47th JSDT meeting, 2002
Akiyoshi Nakano.
Ethylene Vinyl Alcohol Co-Polymer as a High-Performance Membrane: An EVOH Membrane with Excellent Biocompatibility.

Top of Page

kf-201-m

Pertosa et al.
Coagulation Cascade Activation Causes CC Chemokine Receptor-2 Gene Expression and Mononuclear Cell Activation in Hemodialysis Patients.
American Society of Nephrology 16: 2477-2486, 2005
Sirolli et al.
Cell activation and cellular-cellular interactions during hemodialysis: Effect of dialyzer membrane.
THE INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS Vol. 25 / no. 6, pp. 529-537, 2002
Sirolli et al.
LEUKOCYTE ADHESION MOLECULES AND LEUKOCYTE-PLATELET INTERACTIONS DURING HEMODIALYSIS: EFFECTS OF DIFFERENT SYNTHETIC MEMBRANES.
THE INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS Vol. 22, no. 8, pp. 536-542, 1999
Mitsuru Ishizaki, M.D.
Optimum condiitons for continuous use of high-performance membranes - The characteristics of the EVAL membrane in terms of urea kinetics -.
The Kidney Center, Eijinkai-Nagano Hospital, 1998
Masao Ishida.
Blood Compatibility of Ethylene-Vinyl Alcohol Copolymer Dialyzer.
The Cell (Japanese Journal, Hokuryukan & New Science Co., Ltd.) 37: 68-72, 2005
Bonomini et al.
Heterotypic Cell Interactions in Hemodialysis Patients.
Biocompatibility of Dialytic Membrane, pp. 58-80, 2010
Pertosa et al.
Biocompatibility profile of Ethylen-vinyl-alcohol (EVAL), a synthetic dialytic membrane with reduced coagulation and inflammatory activity.
Biocompatibility of Dialytic Membrane, pp.82-106, 2010
Yokota et al.
Use of ethylene vinyl-alcohol block copolymer (EVAL™) dialyzers in the treatment of elderly patients.
47th JSDT meeting, 2002
Akiyoshi Nakano.
Ethylene Vinyl Alcohol Co-Polymer as a High-Performance Membrane: An EVOH Membrane with Excellent Biocompatibility.

Top of Page

Trademark
REXEED, APS and ViE are trademarks of Asahi Kasei Medical Co., Ltd.
EVAL is a trademark for the resin of ethylene vinyl alcohol copolymer (EVOH) manufactured by Kuraray Co., Ltd.

Contact Us

Please feel free to send us any questions you may have about our products and support.

Contact Us

Your Voice

Share your feelings and experiences when using our products.

Your Voice
Note: It might be required in your country that medical devices shall be officially registered and/or approved by an authorized organization. Please contact our representative in your region or contact us to confirm whether the listed products are approved for use. These information may contain general information on medical-related topics and is not meant to provide specialist advice or instructions concerning the products and services sold by Asahi Kasei Medical. Please contact us directly for special inquiries. You should not use this information for diagnosing a health problem or disease but should always consult your own physician.Contact us

Top of page